PRESS RELEASE published on 02/22/2025 at 08:30, 1 year 1 month ago Communiqué de presse : ECCO 2025 : de nouvelles données sur le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn Nouvelles données sur duvakitug présentées par Sanofi et Teva pour traiter colite ulcéreuse et maladie de Crohn au Congrès ECCO 2025, Berlin Maladie De Crohn Sanofi Colite Ulcéreuse Teva Duvakitug
PRESS RELEASE published on 02/22/2025 at 08:30, 1 year 1 month ago Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease Sanofi and Teva Pharmaceuticals present new detailed data from the RELIEVE UCCD study on duvakitug's efficacy in ulcerative colitis and Crohn's disease at ECCO 2025, demonstrating potential for phase 3 program in H2 2025 Ulcerative Colitis Sanofi Teva Pharmaceuticals Crohn's Disease RELIEVE UCCD Study
BRIEF published on 02/19/2025 at 07:35, 1 year 1 month ago Sanofi and CD&R Finalize Opella Share Purchase Agreement Share Purchase Regulatory Approvals Sanofi CD&R Opella
BRIEF published on 02/19/2025 at 07:35, 1 year 1 month ago Sanofi et CD&R finalisent l'accord d'achat d'actions d'Opella Achat D'actions Approbations Réglementaires Sanofi Opella CD-R
PRESS RELEASE published on 02/19/2025 at 07:30, 1 year 1 month ago Press Release: Sanofi and CD&R sign Opella share purchase agreement Sanofi and CD&R sign share purchase agreement for Opella, with Bpifrance as minority shareholder. Transaction expected to close in Q2 2025, subject to regulatory approvals Share Purchase Agreement Sanofi Bpifrance CD&R Opella
PRESS RELEASE published on 02/19/2025 at 07:30, 1 year 1 month ago Communiqué de presse : Sanofi et CD&R annoncent la signature de l’accord d’achat des actions d’Opella Sanofi et CD&R signent l’accord d’achat d’actions d’Opella. Bpifrance participe en tant qu'actionnaire minoritaire. Opération prévue au deuxième trimestre 2025 Acquisition Sanofi Bpifrance CD&R Opella
BRIEF published on 02/13/2025 at 20:13, 1 year 1 month ago Sanofi Files 2024 Financial Reports with SEC and AMF Financial Report 2024 SEC Filing Sanofi AMF Compliance
BRIEF published on 02/13/2025 at 20:13, 1 year 1 month ago Sanofi dépose ses rapports financiers 2024 auprès de la SEC et de l'AMF Rapport Financier 2024 Sanofi Dépôt Auprès De La SEC Conformité AMF
PRESS RELEASE published on 02/13/2025 at 20:08, 1 year 1 month ago Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Sanofi files 2024 U.S. Form 20-F and French Annual Financial Report. Documents available online. Company focused on healthcare innovation Innovation Financial Report Healthcare Form 20-F Sanofi
PRESS RELEASE published on 02/13/2025 at 20:08, 1 year 1 month ago Communiqué de presse : Dépôt du Document d’Enregistrement Universel 2024, contenant le Rapport Financier Annuel, et du « Form 20-F » américain Sanofi dépose son Document d’Enregistrement Universel 2024 et le « Form 20-F » américain, incluant le Rapport Financier Annuel et des informations clés, pour consultation en ligne AMF Rapport Financier Annuel Form 20-F Sanofi Document D’Enregistrement Universel 2024
Published on 03/23/2026 at 21:18, 19 minutes ago Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 7 hours 32 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 7 hours 37 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 8 hours 32 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 9 hours 5 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 21:05, 32 minutes ago Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 21:05, 32 minutes ago Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 37 minutes ago Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 20:55, 42 minutes ago Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable
Published on 03/23/2026 at 19:08, 2 hours 29 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 2 hours 29 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 17:45, 3 hours 52 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 3 hours 52 minutes ago En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde